168 related articles for article (PubMed ID: 19891600)
1. Anti-copper therapies in Alzheimer's disease: new concepts.
Squitti R; Zito G
Recent Pat CNS Drug Discov; 2009 Nov; 4(3):209-19. PubMed ID: 19891600
[TBL] [Abstract][Full Text] [Related]
2. Agents complexing copper as a therapeutic strategy for the treatment of Alzheimer's disease.
Squitti R; Salustri C
Curr Alzheimer Res; 2009 Dec; 6(6):476-87. PubMed ID: 19747159
[TBL] [Abstract][Full Text] [Related]
3. Metal complexing agents as therapies for Alzheimer's disease.
Bush AI
Neurobiol Aging; 2002; 23(6):1031-8. PubMed ID: 12470799
[TBL] [Abstract][Full Text] [Related]
4. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
Domingo JL
J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
[TBL] [Abstract][Full Text] [Related]
5. Metals in Alzheimer's disease: a systemic perspective.
Squitti R
Front Biosci (Landmark Ed); 2012 Jan; 17(2):451-72. PubMed ID: 22201755
[TBL] [Abstract][Full Text] [Related]
6. Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.
Ejaz HW; Wang W; Lang M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081348
[TBL] [Abstract][Full Text] [Related]
7. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
8. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
Cuajungco MP; Fagét KY
Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
[TBL] [Abstract][Full Text] [Related]
9. Rebalancing metal dyshomeostasis for Alzheimer's disease therapy.
Yang GJ; Liu H; Ma DL; Leung CH
J Biol Inorg Chem; 2019 Dec; 24(8):1159-1170. PubMed ID: 31486954
[TBL] [Abstract][Full Text] [Related]
10. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-beta metal interaction and metal chelation.
Cuajungco MP; Frederickson CJ; Bush AI
Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
[TBL] [Abstract][Full Text] [Related]
12. Transition metal chelator therapy--a potential treatment for Alzheimer's disease?
Gnjec A; Fonte JA; Atwood C; Martins RN
Front Biosci; 2002 Apr; 7():d1016-23. PubMed ID: 11897554
[TBL] [Abstract][Full Text] [Related]
13. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
[TBL] [Abstract][Full Text] [Related]
14. Current status of metals as therapeutic targets in Alzheimer's disease.
Finefrock AE; Bush AI; Doraiswamy PM
J Am Geriatr Soc; 2003 Aug; 51(8):1143-8. PubMed ID: 12890080
[TBL] [Abstract][Full Text] [Related]
15. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
[TBL] [Abstract][Full Text] [Related]
16. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
17. Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD.
Squitti R
J Trace Elem Med Biol; 2014 Oct; 28(4):482-5. PubMed ID: 25066791
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
Price KA; Crouch PJ; White AR
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
[TBL] [Abstract][Full Text] [Related]
19. Metal-Organic Frameworks Harness Cu Chelating and Photooxidation Against Amyloid β Aggregation in Vivo.
Yu D; Guan Y; Bai F; Du Z; Gao N; Ren J; Qu X
Chemistry; 2019 Mar; 25(14):3489-3495. PubMed ID: 30601592
[TBL] [Abstract][Full Text] [Related]
20. Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Cherny RA; Barnham KJ; Lynch T; Volitakis I; Li QX; McLean CA; Multhaup G; Beyreuther K; Tanzi RE; Masters CL; Bush AI
J Struct Biol; 2000 Jun; 130(2-3):209-16. PubMed ID: 10940226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]